Abstract:Cocaine use disorder (CUD) is a chronic neuropsychiatric disorder estimated to effect 1–3% of the population. Activity-dependent neuroprotective protein (ADNP) is essential for brain development and functioning, shown to be protective in fetal alcohol syndrome and to regulate alcohol consumption in adult mice. The goal of this study was to characterize the role of ADNP, and its active peptide NAP (NAPVSIPQ), which is also known as davunetide (investigational drug) in mediating cocaine-induced neuroadaptations. Real time PCR was used to test levels of Adnp and Adnp2 in the nucleus accumbens (NAc), ventral tegmental area (VTA), and dorsal hippocampus (DH) of cocaine-treated mice (15 mg/kg). Adnp heterozygous (Adnp +/− )and wild-type (Adnp +/− ) mice were further tagged with excitatory neuronal membrane-expressing green fluorescent protein (GFP) that allowed for in vivo synaptic quantification. The mice were treated with cocaine (5 injections; 15 mg/kg once every other day) with or without NAP daily injections (0.4 μg/0.1 ml) and sacrificed following the last treatment. We analyzed hippocampal CA1 pyramidal cells from 3D confocal images using the Imaris x64.8.1.2 (Oxford Instruments) software to measure changes in dendritic spine density and morphology. In silico ADNP/NAP/cocaine structural modeling was performed as before. Cocaine decreased Adnp and Adnp2 expression 2 h after injection in the NAc and VTA of male mice, with mRNA levels returning to baseline levels after 24 h. Cocaine further reduced hippocampal spine density, particularly synaptically weaker immature thin and stubby spines, in male Adnp +/+ ) mice while increasing synaptically stronger mature (mushroom) spines in Adnp +/− ) male mice and thin and stubby spines in females. Lastly, we showed that cocaine interacts with ADNP on a zinc finger domain identical to ketamine and adjacent to a NAP-zinc finger interaction site. Our results implicate ADNP in cocaine abuse, further placing the ADNP gene as a key regulator in neuropsychiatric disorders. Ketamine/cocaine and NAP treatment may be interchangeable to some degree, implicating an interaction with adjacent zinc finger motifs on ADNP and suggestive of a potential sex-dependent, non-addictive NAP treatment for CUD.

Noradrenergic lesion antagonizes desipramine-induced adaptation of NMDA receptors

Postsynaptic Α -2 Adrenergic Receptors Are Critical for the Antidepressant-Like Effects of Desipramine on Behavior

Noradrenaline activation of hippocampal dopamine D1 receptors promotes antidepressant effects

Desipramine induces eryptosis in human erythrocytes, an effect blunted by nitric oxide donor sodium nitroprusside and N-acetyl-L-cysteine but enhanced by Calcium depletion

Norepinephrine transporter function and desipramine: residual drug effects versus short-term regulation

Noradrenergic Activity Regulated Dexamethasone-Induced Increase of 5-Ht3 Receptor-Mediated Glutamate Release in the Rat'S Prelimbic Cortex

The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo

Protective effects of desipramine against 3-nitropropionic acid-induced behavioral dysfunctions in mice

Loss of the sustained antidepressant-like effect of (2R,6R)-hydroxynorketamine in NMDA receptor GluN2D subunit knockout mice

Amoxapine Inhibits Delayed Outward Rectifier K+ Currents in Cerebellar Granule Cells Via Dopamine Receptor and Protein Kinase A Activation

Sex-Specific ADNP/NAP (Davunetide) Regulation of Cocaine-Induced Plasticity

Prolonged Desipramine Treatment Increases the Production of Interleukin-10, an Anti-Inflammatory Cytokine, in C57bl/6 Mice Subjected to the Chronic Mild Stress Model of Depression

Memantine‐induced functional rewiring of the glutamate synapse in the striatum of dopamine transporter knockout rats

Both Glutamate Receptor Antagonists and Prefrontal Cortex Lesions Prevent Induction of Cocaine Sensitization and Associated Neuroadaptations.

Dynorphin up-regulation in the dentate granule cell mossy fiber pathway following chronic inhibition of GluN2B-containing NMDAR is associated with increased CREB (Ser 133) phosphorylation, but is independent of BDNF/TrkB signaling pathways

The Effect of Repeated Amitriptyline and Desipramine Administration on Cytokine Release in C57BL/6 Mice

Effect of Noradrenaline on the Facial Stimulation-Evoked Mossy Fiber-Granule Cell Synaptic Transmission in Mouse Cerebellar Cortex

Modulating sensory gating in healthy volunteers: The effects of desipramine and haloperidol

N-Substituted-3-alkoxy-derivatives of dextromethorphan are functional NMDA receptor antagonists in vivo: Evidence from an NMDA-induced seizure model in rats

Antidepressant Effect of NMDA Receptor and Its Sub-Receptor Antagonists in Rats

Influence of CGS 21680, a selective adenosine A2A receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice